✦ LIBER ✦

Phase I study of irinotecan (CPT-11) and cisplatin (CDDP) combination in metastatic non-small cell lung cancer (NSCLC)

✍ Scribed by Kakolyris, S; Kouroussis, C; Souglakos, J; Androulakis, N; Mavroudis, D; Kalbakis, K; Kotsakis, A; Sara, E; Agelaki, S; Prinianakis, G; Vardakis, N; Samonis, G; Georgoulias, V

Book ID: 118575460
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 96 KB
Volume: 21
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(98)90061-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Irinotecan (CPT-11) in combination with

Irinotecan (CPT-11) in combination with weekly administration of cisplatin (CDDP) for non-small-cell lung cancer

✍ Kunihiko Kobayashi; Ayako Shinbara; Mitsuhiro Kamimura; Yuichiro Takeda; Koichir 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 405 KB

Phase I study of irinotecan (CPT-11) and

Phase I study of irinotecan (CPT-11) and cisplatin (CDDP) with concurrent thoracic radiotherapy (TRT) in locally advanced non-small cell lung cancer (NSCLC)

✍ Nakamura, Y; Fukuda, M; Fukuda, Mi; Soda, H; Ichiki, M; Takatani, H; Kanda, T; K 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Fractionated administration of cisplatin

Fractionated administration of cisplatin (CDDP) and irinotecan (CPT-11) in patients with stage IIIB and IV non-small-cell lung cancer (NSCLC): A phase II study

✍ Takata, I; Ueoka, H; Kiura, K; Hiraki, S; Eguchi, K; Okimoto, N; Harita, S; Yone 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Cisplatin (CDDP) and irinotecan (CPT-11)

Cisplatin (CDDP) and irinotecan (CPT-11) versus CDDP and vindesine (VDS) in advanced (stage IIIB and stage IV) non-small cell lung cancer (NSCLC). A multicenter phase III study

✍ H. Kunitoh; N. Saijo; K. Nagao; Y. Ohashi; H. Niitani 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 350 KB

Phase I study of irinotecan (CPT-11), ci

Phase I study of irinotecan (CPT-11), cisplatin (cDDP) and radical thoracic radiation (TRT) in the treatment of locally advanced non-small cell lung carcinoma (NSCLC)

✍ Langer, C; Movsas, B; Huang, C; Millenson, M; Maiale, C; Donahue, J; Treat, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 118 KB

The final results of a randomized phase

The final results of a randomized phase III trial comparing irinotecan (CPT-11) and cisplatin (CDDP) with vindesine (VDS) and CDDP in advanced non-small cell lung cancer (NSCLC)

✍ Takiguchi, Y; Nagao, K; Nishiwaki, Y; Yokoyama, A; Saijo, N; Ohashi, Y; Niitani, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 219 KB